Role of Plasminogen System Components in Focal Cerebral Ischemic Infarction: A Gene Targeting and Gene Transfer Study in Mice
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Background —The role of plasminogen system components in focal cerebral ischemic infarction (FCI) was studied in mice deficient in plasminogen (Plg −/− ), in tissue or urokinase plasminogen activator (tPA −/− or uPA −/− ), or in plasminogen activator inhibitor-1 or α 2 -antiplasmin (PAI-1 −/− or α 2 -AP −/− ). Methods and Results —FCI was produced by ligation of the left middle cerebral artery and measured after 24 hours by planimetry of stained brain slices. In control (wild-type) mice, infarct size was 7.6±1.1 mm 3 (mean±SEM), uPA −/− mice had similar infarcts (7.8±1.0 mm 3 , P =NS), tPA −/− mice smaller (2.6±0.80 mm 3 , P <0.0001), PAI-1 −/− mice larger (16±0.52 mm 3 , P <0.0001), and Plg −/− mice larger (12±1.2 mm 3 , P =0.037) infarcts. α 2 -AP −/− mice had smaller infarcts (2.2±1.1 mm 3 , P <0.0001 versus wild-type), which increased to 13±2.5 mm 3 ( P <0.005 versus α 2 -AP −/− ) after intravenous injection of human α 2 -AP. Injection into α 2 -AP −/− mice of Fab fragments of affinospecific rabbit IgG against human α 2 -AP, after injection of 200 μg human α 2 -AP, reduced FCI from 11±1.5 to 5.1±1.1 mm 3 ( P =0.004). Conclusions —Plg system components affect FCI at 2 different levels: (1) reduction of tPA activity ( tPA gene inactivation) reduces whereas its augmentation ( PAI-1 gene inactivation) increases infarct size, and (2) reduction of Plg activity ( Plg gene inactivation or α 2 -AP injection) increases whereas its augmentation (α 2 - AP gene inactivation or α 2 -AP neutralization) reduces infarct size. Inhibition of α 2 -AP may constitute a potential avenue to treatment of FCI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Characteristics of a human cell line transformed by DNA from human adenovirus type 5
Graham, F. L., Russell, W. C., Smiley, J., & Nairn, R. (1977) · Journal of General Virology · doi:10.1099/0022-1317-36-1-59 · Cited by 4,793
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
Coyle, J. T., & Puttfarcken, P. (1993) · Science · doi:10.1126/science.7901908 · Cited by 3,762
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,658
Bederson, J. B., Pitts, L. H., Germano, S. M., Nishimura, M. C., Davis, R. L., & Bartkowski, H. M. (1986) · Stroke · doi:10.1161/01.str.17.6.1304 · Cited by 1,277
Physiological consequences of loss of plasminogen activator gene function in mice
Carmeliet, P., Schoonjans, L., Kieckens, L., Ream, B., Degen, J., Bronson, R., De Vos, R., van den Oord, J. J., Collen, D., & Mulligan, R. C. (1994) · Nature · doi:10.1038/368419a0 · Cited by 1,037
Self-citationExcitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator
Tsirka, S. E., Gualandris, A., Amaral, D. G., & Strickland, S. (1995) · Nature · doi:10.1038/377340a0 · Cited by 663
Neuronal Death in the Hippocampus Is Promoted by Plasmin-Catalyzed Degradation of Laminin
Chen, Z.-L., & Strickland, S. (1997) · Cell · doi:10.1016/s0092-8674(00)80483-3 · Cited by 632
Wang, Y. F., Tsirka, S. E., Strickland, S., Stieg, P. E., Soriano, S. G., & Lipton, S. A. (1998) · Nature Medicine · doi:10.1038/nm0298-228 · Cited by 630
Cited by
Yepes, M., Sandkvist, M., Moore, E. G., Bugge, T. H., Strickland, D. K., & Lawrence, D. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19212 · Cited by 566
Protective Role of Reactive Astrocytes in Brain Ischemia
Li, L., Lundkvist, A., Andersson, D., Wilhelmsson, U., Nagai, N., Pardo, A. C., Nodin, C., Ståhlberg, A., Aprico, K., Larsson, K., et al. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600546 · Cited by 505
“Protective role of reactive astrocytes in brain ischemia Lizhen Li1, Andrea Lundkvist1, Daniel Andersson1, Ulrika Wilhelmsson1, Nobuo Nagai2, Andrea C Pardo3, Christina Nodin1, Anders Ståhlberg4, Karina Aprico1, Kerstin Larsson5, Takeshi Yabe6, Lieve Moons2, Andrew Fotheringham7, Ioan Davies7, Peter Carmeliet2, Joan…”
BackgroundMethodSelf-citationSu, E. J., Fredriksson, L., Geyer, M., Folestad, E., Cale, J., Andrae, J., Gao, Y., Pietras, K., Mann, K., Yepes, M., et al. (2008) · Nature Medicine · doi:10.1038/nm1787 · Cited by 468
Wilhelmsson, U., Li, L., Pekna, M., Berthold, C.-H., Blom, S., Eliasson, C., Renner, O., Bushong, E., Ellisman, M., Morgan, T. E., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0820-04.2004 · Cited by 455
Xi, G., Reiser, G., & Keep, R. F. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01268.x · Cited by 354
Lo, E. H., Wang, X., & Cuzner, M. L. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10270 · Cited by 310
Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic
Yepes, M., Roussel, B. D., Ali, C., & Vivien, D. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.09.006 · Cited by 286
Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis
Yepes, M., Sandkvist, M., Wong, M. K. K., Coleman, T. A., Smith, E., Cohan, S. L., & Lawrence, D. A. (2000) · Blood · doi:10.1182/blood.v96.2.569 · Cited by 278
Serine proteases and brain damage – is there a link?
Gingrich, M. B., & Traynelis, S. F. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01617-9 · Cited by 274
Melchor, J. P., Pawlak, R., & Strickland, S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-26-08867.2003 · Cited by 202
Thiyagarajan, M., Fernández, J. A., Lane, S. M., Griffin, J. H., & Zlokovic, B. V. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3485-08.2008 · Cited by 105
“1A–E), consistent with its reported neurotoxicity seen previously in models of transient brain ischemia (Wang et al., 1998; Nagai et al., 1999; Nicole et al., 2001; Liu et al., 2004; Cheng et al., 2006).”
BackgroundResultShen, L. H., Xin, H., Li, Y., Zhang, R. L., Cui, Y., Zhang, L., Lu, M., Zhang, Z. G., & Chopp, M. (2011) · Stroke · doi:10.1161/strokeaha.110.593863 · Cited by 51
Kawao, N., Nagai, N., Tamura, Y., Okada, K., Yano, M., Suzuki, Y., Umemura, K., Ueshima, S., & Matsuo, O. (2011) · Thrombosis and Haemostasis · doi:10.1160/th10-08-0516 · Cited by 17
“The PA/plasminogen system has many physiological and pathophysiological functions in mammals (11, 13, 14).”
BackgroundSelf-citation
Metadata
- Authors
- Nagai, N., De Mol, M., Lijnen, H. R., Carmeliet, P., & Collen, D.
- Venue
- Circulation
- Published
- 1999-05-11
- Volume
- 99
- Issue
- 18
- Pages
- 2440-2444
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2023419933
- Cited by
- 252
- References
- 26
- FWCI
- 8.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.